Literature DB >> 16410350

The relation between visceral fat measurement and torso level--is one level better than another? The Atherosclerosis Risk in Communities Study, 1990-1992.

Meghan Warren1, Pamela J Schreiner, James G Terry.   

Abstract

Intraabdominal fat (IAF) area is often measured indirectly in epidemiologic studies. The authors recruited 147 participants from the second examination (1990-1992) of the Atherosclerosis Risk in Communities Study to examine IAF area and determine whether there were differences in IAF area and distribution by location. Magnetic resonance imaging was used to image four 10-mm slices between the second and fourth lumbar vertebrae by an inverse recovery method, and IAF was calculated from each image. The authors constructed gender-specific mixed models with IAF area as the outcome and the location of imaging along the torso as the independent variable, using random intercepts to account for between-person variation in IAF area. The torso location of IAF measurement was a significant predictor of IAF area in both men (p = 0.02) and women (p < 0.0001) after adjustment for body mass index. A significant positive interaction between age and location was seen in men, with increasing IAF area moving down the torso with older ages. Using magnetic resonance imaging, location along the torso yields different IAF areas and distributions independently of body mass index in both genders, with measurement at the second lumbar vertebra (slightly above the umbilicus) capturing the largest amount of IAF. Studies that attempt to link IAF with cardiovascular disease risk factors should consider measurement location to accurately capture the association.

Entities:  

Mesh:

Year:  2006        PMID: 16410350     DOI: 10.1093/aje/kwj049

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  7 in total

1.  Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans.

Authors:  B J Klopfenstein; M S Kim; C M Krisky; J Szumowski; W D Rooney; J Q Purnell
Journal:  Br J Radiol       Date:  2012-04-18       Impact factor: 3.039

2.  The ADRB3 Trp64Arg variant and obesity in African-American breast cancer cases.

Authors:  R McKean-Cowdin; X Li; L Bernstein; A McTiernan; R Ballard-Barbash; W J Gauderman; F Gilliland
Journal:  Int J Obes (Lond)       Date:  2007-01-30       Impact factor: 5.095

3.  Validation of a semi-automated technique to accurately measure abdominal fat distribution using CT and MRI for clinical risk stratification.

Authors:  Mohammed A Waduud; Amal Sharaf; Iain Roy; Rosario Lopez-Gonzalez; Andrew Hart; David McGill; Giles Roditi; John Biddlestone
Journal:  Br J Radiol       Date:  2017-01-05       Impact factor: 3.039

4.  Approximation of total visceral adipose tissue with a single magnetic resonance image.

Authors:  Ellen W Demerath; Wei Shen; Miryoung Lee; Audrey C Choh; Stefan A Czerwinski; Roger M Siervogel; Bradford Towne
Journal:  Am J Clin Nutr       Date:  2007-02       Impact factor: 7.045

5.  Anatomical patterning of visceral adipose tissue: race, sex, and age variation.

Authors:  Ellen W Demerath; Shumei S Sun; Nikki Rogers; Miryoung Lee; Derek Reed; Audrey C Choh; William Couch; Stefan A Czerwinski; W Cameron Chumlea; Roger M Siervogel; Bradford Towne
Journal:  Obesity (Silver Spring)       Date:  2007-12       Impact factor: 5.002

6.  Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome.

Authors:  Connie Yip; Charlotte Dinkel; Abhishek Mahajan; Musib Siddique; Gary J R Cook; Vicky Goh
Journal:  Insights Imaging       Date:  2015-06-13

7.  Occurrence of Diabetes Mellitus in Obese Nondiabetic Patients, with Correlative Analysis of Visceral Fat, Fasting Insulin, and Insulin Resistance: A 3-year Follow-up Study (Mysore Visceral Adiposity in Diabetes Follow-up Study).

Authors:  M Premanath; H Basavanagowdappa; M Mahesh; M Suresh Babu
Journal:  Indian J Endocrinol Metab       Date:  2017 Mar-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.